| Pharmaceutical active ingredients: |
| Potassium GuaiacolsulfonatePromethazine Hydrochloride |
| Available forms, composition and doses of Phenergan Expectorant: |
| Syrup; Oral; Potassium Guaiacolsulfonate 40 mg; Promethazine Hydrochloride 5.65 mg / ml |
| Phenergan Expectorant medical category: |
| Human:Expectorants |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R05CA09 - GuaiacolsulfonateR06AD52 - Promethazine, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| WyethNovartisSanofi-Aventis |
| Related documents and information about Phenergan Expectorant: |
| Phenergan prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Phenemalum | Phenobarbital | Unidentified Pharmaceutical Company |
| Phenephrin | Codeine Phosphate; Guaifenesin; Menthol; Phenylephrine Hydrochloride | Nelson Laboratories |
| Phenerbel-S | Belladonna; Ergotamine Tartrate; Phenobarbital | Watson Pharmaceuticals |
| Phenergan | Promethazine Hydrochloride | Wyeth; Celltech; Columbia Laboratories; Institute of Pharmaceutical Research and Technology; Nicholas Piramal; Novartis; Sanofi-Aventis; UCB Pharma |
| Phenergan Compound Expectorant | Citric Acid; Ipecacuanha; Promethazine Hydrochloride; Sulfogaiacol | Wyeth; Sanofi-Aventis |
| Phenergan Expectorant with Codeine | Codeine Phosphate; Potassium Guaiacolsulfonate; Promethazine Hydrochloride | Wyeth; Columbia Laboratories; Novartis; Sanofi-Aventis |
| Phenergan Fortis | Promethazine Hydrochloride | Wyeth |
| Phenergan Plain | Promethazine Hydrochloride | Wyeth |
| Phenergan VC | Phenylephrine Hydrochloride; Promethazine Hydrochloride | Wyeth |
| Phenergan VC Expectorant | Phenylephrine Hydrochloride; Potassium Guaiacolsulfonate; Promethazine Hydrochloride | Wyeth; Novartis; Sanofi-Aventis |